The new facility will offer end-to-end pharmaceutical development and manufactur...
Epkinly’s approval was supported by the findings from the Phase I/II EPCORE NHL-...
In the latest update of the ongoing Covid-19 mRNA vaccine dispute, CureVac has s...
Following a year of HRT shortages in 2022, the UK is issuing a serious shortage ...
This marks another setback for Ocaliva in this indication, as the race towards t...
SinoMab BioScience intends to commence a Phase I clinical trial in China to eval...
Ironwood expects the deal to strengthen its portfolio and pipeline to advance th...
In the second edition of Money Moves, we look at how European funding could help...
An early trial of a drug offer hope for people with ATTR-CM, a type of heart dis...
A Stanford team has built soft, stretchable electronic skin that aims to restore...
Mpox has “a substantial risk of resurgence” health officials say, warning people...
While MS is not a terminal diagnosis, the effect of the disease on the CNS can s...
The NDA was supported by data obtained from the Phase I clinical trial and the P...
The financing will help to fast-track the development of other in vivo programmi...
AbbVie’s blockbuster drug Rinvoq earned its seventh approval to become the first...
The justices’ verdict concludes a long legal battle between the companies over p...
